Clinical Trial Update: Therapeutic Initial Heparin Dosing for Patients With Clots or Certain Heart Conditions Admitted to the Hospital [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the initial therapeutic dosing of heparin for hospitalized patients with clots or certain heart conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Coronary Syndrome
• Deep Vein Thrombosis
• Mechanical Heart Valve Replacement
• Pulmonary Embolism

Drugs mentioned

• Heparin (unfractionated heparin)

Snippet

Sponsor: Inova Health Care Services | Conditions: Pulmonary Embolism, Deep Vein Thrombosis | Phase 4 | Status: ACTIVE_NOT_RECRUITING